cbdMD Inc (YCBD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, cbdMD Inc (YCBD) has a cash flow conversion efficiency ratio of -0.115x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-704.20K) by net assets ($6.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See YCBD defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
cbdMD Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how cbdMD Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
cbdMD Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of cbdMD Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Blockmate Ventures Inc
V:MATE
|
0.102x |
|
Openlearning Ltd
AU:OLL
|
0.356x |
|
Bluefield Solar Income Fund
LSE:BSIF
|
-0.001x |
|
Cambridge Technology Enterprises Limited
NSE:CTE
|
0.319x |
|
MOSTOSTAL Płock SA
WAR:MSP
|
-0.174x |
|
Triboron International AB (publ)
ST:TRIBO-B
|
0.092x |
|
Novatti Group Ltd
AU:NOV
|
-0.021x |
|
Luminar Technologies
NASDAQ:LAZR
|
0.159x |
Annual Cash Flow Conversion Efficiency for cbdMD Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of cbdMD Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see YCBD stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | $1.96 Million | $-352.79K | -0.180x | +62.28% |
| 2023-09-30 | $9.03 Million | $-4.30 Million | -0.476x | -0.01% |
| 2022-09-30 | $31.42 Million | $-14.97 Million | -0.476x | -248.57% |
| 2021-09-30 | $103.14 Million | $-14.09 Million | -0.137x | -1.45% |
| 2020-09-30 | $79.18 Million | $-10.66 Million | -0.135x | +67.07% |
| 2019-09-30 | $37.60 Million | $-15.38 Million | -0.409x | -2.87% |
| 2018-09-30 | $14.02 Million | $-5.57 Million | -0.398x | +12.15% |
| 2017-09-30 | $5.15 Million | $-2.33 Million | -0.452x | -104.57% |
| 2016-09-30 | $-292.73K | $-2.90 Million | 9.898x | +840.59% |
| 2015-09-30 | $1.28 Million | $-1.71 Million | -1.336x | -- |
About cbdMD Inc
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated p… Read more